Each month, Marc provides a financial analysis of the Australian biotechnology industry, focusing on a specific company’s intellectual property, stage of development, balance sheet and share price performance.

Each company report is a detailed snapshot of the financial state of the enterprise with Marc Sinatra’s recommendation.

Marc also comments on topical issues as and when they occur in his ongoing Bioguide Brief Notes - see below.